Life Tech Eyes Long-Term Opportunities in Synthetic Bio Space | GenomeWeb

By Tony Fong

NEW YORK (GenomeWeb News) – With two recent deals, Life Technologies is positioning itself to capitalize on what could be the next big market opportunity in the life sciences.

During the past two weeks the Carlsbad, Calif.-based company has completed two deals giving it a seat at the synthetic biology table — a field with a market size that has been projected to reach $2.4 billion by 2013.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."